Global Search

Search articles, concepts, and chapters

RetinaNovember 201910 citations

LATE-ONSET OCULAR HYPERTENSION AFTER VITRECTOMY: A Multicenter Study of 6,048 Eyes.

Reibaldi Michele, Avitabile Teresio, Russo Andrea, Bonfiglio Vincenza, Mariotti Cesare, Romano Mario R, Boscia Francesco, Cennamo Gilda, Fallico Matteo, Parisi Guglielmo


AI Summary

This study found late-onset ocular hypertension occurred in 4.9% of vitrectomized eyes, primarily linked to intraoperative triamcinolone and post-vitrectomy pseudophakia/aphakia, highlighting the need for vigilance.

Abstract

Purpose

To determine the incidence and risk factors for late-onset ocular hypertension (LOH) after vitrectomy.

Methods

From the electronic medical records of consecutive patients who underwent primary vitrectomy, from January 2010 to December 2015, at 5 tertiary vitreoretinal centers in Italy, patient demographics, systemic, ophthalmic, operative, and postoperative data were drawn. Main outcome measure was the presence of LOH, defined as intraocular pressure >21 mmHg detected more than 2 months after vitrectomy on at least 2 consecutive visits.

Results

Among 6,048 patients, LOH was found in 294 (4.9%) vitrectomized eyes and in 87 (1.4%) fellow eyes, (chi square; P < 0.001). Multivariable logistic regression showed that significant risk factors for developing LOH included intraoperative triamcinolone use (odds ratio [OR], 7.62; P < 0.001), longer axial length (OR, 1.55; P = 3.023), preoperative higher intraocular pressure (OR, 1.81; P = 0.003), and postvitrectomy pseudophakic/aphakic status (OR, 2.04; P < 0.001). Decision-tree analysis showed that the stronger predictor of LOH was intraoperative triamcinolone use (P < 0.001). Secondary predictors were a preoperative intraocular pressure more than 15 mmHg (P < 0.001) in eyes that use triamcinolone, and postvitrectomy pseudophakic/aphakic status (P = 0.007) in eyes that did not use triamcinolone.

Conclusion

Late-onset ocular hypertension occurred in 4.9% of vitrectomized eyes. The main risk factors were intraoperative use of triamcinolone and postvitrectomy pseudophakic/aphakic status.


MeSH Terms

AgedFemaleFollow-Up StudiesHumansIncidenceIntraocular PressureItalyMaleOcular HypertensionRetinal DiseasesRetrospective StudiesRisk FactorsTime FactorsVitrectomy

Key Concepts5

Late-onset ocular hypertension (LOH), defined as intraocular pressure >21 mmHg detected more than 2 months after vitrectomy on at least 2 consecutive visits, occurred in 4.9% of 6,048 vitrectomized eyes.

EpidemiologyCohortMulticenter Retrospective Cohort Studyn=6,048 vitrectomized eyesCh10Ch27

Intraoperative triamcinolone use was a significant risk factor for developing late-onset ocular hypertension after vitrectomy (odds ratio [OR], 7.62; P < 0.001) in a multicenter study of 6,048 vitrectomized eyes.

PrognosisCohortMulticenter Retrospective Cohort Studyn=6,048 vitrectomized eyesCh23Ch27

Postvitrectomy pseudophakic/aphakic status was a significant risk factor for developing late-onset ocular hypertension after vitrectomy (odds ratio [OR], 2.04; P < 0.001) in a multicenter study of 6,048 vitrectomized eyes.

PrognosisCohortMulticenter Retrospective Cohort Studyn=6,048 vitrectomized eyesCh19Ch27

Longer axial length (OR, 1.55; P = 3.023) and preoperative higher intraocular pressure (OR, 1.81; P = 0.003) were identified as significant risk factors for developing late-onset ocular hypertension after vitrectomy in a multicenter study of 6,048 vitrectomized eyes.

PrognosisCohortMulticenter Retrospective Cohort Studyn=6,048 vitrectomized eyesCh10Ch27

A multicenter retrospective cohort study of 6,048 patients who underwent primary vitrectomy between January 2010 and December 2015 at 5 tertiary vitreoretinal centers in Italy investigated the incidence and risk factors for late-onset ocular hypertension after vitrectomy.

MethodologyCohortMulticenter Retrospective Cohort Studyn=6,048 patientsCh10

Is this article assigned to the wrong chapter(s)? Let us know.